KR970005190B1 - 피롤리딘 유도체 - Google Patents

피롤리딘 유도체

Info

Publication number
KR970005190B1
KR970005190B1 KR1019880005091A KR880005091A KR970005190B1 KR 970005190 B1 KR970005190 B1 KR 970005190B1 KR 1019880005091 A KR1019880005091 A KR 1019880005091A KR 880005091 A KR880005091 A KR 880005091A KR 970005190 B1 KR970005190 B1 KR 970005190B1
Authority
KR
South Korea
Prior art keywords
alkyl
compound
salt
carboxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019880005091A
Other languages
English (en)
Korean (ko)
Other versions
KR880013889A (ko
Inventor
세토이 히로이우끼
히라이 히데오
마루사와 히로시
구로다 아끼오
다나까 히로가쭈
하시모또 마사시
Original Assignee
후지사와 야쿠힌 고오교오 가부시기가이샤
도모끼지로오 후지사와
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878710352A external-priority patent/GB8710352D0/en
Priority claimed from GB878716438A external-priority patent/GB8716438D0/en
Priority claimed from GB878730027A external-priority patent/GB8730027D0/en
Application filed by 후지사와 야쿠힌 고오교오 가부시기가이샤, 도모끼지로오 후지사와 filed Critical 후지사와 야쿠힌 고오교오 가부시기가이샤
Publication of KR880013889A publication Critical patent/KR880013889A/ko
Application granted granted Critical
Publication of KR970005190B1 publication Critical patent/KR970005190B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019880005091A 1987-05-01 1988-04-30 피롤리딘 유도체 Expired - Fee Related KR970005190B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB878710352A GB8710352D0 (en) 1987-05-01 1987-05-01 Pyrrolidine derivatives
GB8710352 1987-05-01
GB8716438 1987-07-13
GB878716438A GB8716438D0 (en) 1987-07-13 1987-07-13 Pyrrolidine derivatives
GB878730027A GB8730027D0 (en) 1987-12-23 1987-12-23 Pyrrolidine derivatives
GB8730027 1987-12-23

Publications (2)

Publication Number Publication Date
KR880013889A KR880013889A (ko) 1988-12-22
KR970005190B1 true KR970005190B1 (ko) 1997-04-14

Family

ID=27263412

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880005091A Expired - Fee Related KR970005190B1 (ko) 1987-05-01 1988-04-30 피롤리딘 유도체

Country Status (18)

Country Link
US (1) US4916152A (enExample)
EP (1) EP0289911B1 (enExample)
JP (1) JPS63295553A (enExample)
KR (1) KR970005190B1 (enExample)
CN (1) CN1020899C (enExample)
AR (1) AR247879A1 (enExample)
AU (1) AU613360B2 (enExample)
CA (1) CA1329391C (enExample)
DE (1) DE3881755T2 (enExample)
DK (1) DK233888A (enExample)
ES (1) ES2054729T3 (enExample)
FI (1) FI88716C (enExample)
HU (1) HU208671B (enExample)
IE (1) IE62862B1 (enExample)
IL (1) IL86173A (enExample)
NO (1) NO173330C (enExample)
PH (1) PH24950A (enExample)
PT (1) PT87359B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718031B2 (en) 2005-01-05 2010-05-18 Samsung Mobile Display Co., Ltd. Mask frame and method of fixing mask on the mask frame

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5264453A (en) * 1988-10-31 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
FR2685325B1 (fr) * 1991-12-20 1994-02-04 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2687146B1 (fr) * 1992-02-12 1994-04-01 Adir Cie Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
HUT70217A (en) * 1992-07-02 1995-09-28 Fujisawa Pharmaceutical Co Process for producing pyrrolidine derivative and salt thereof
CA2930393C (en) * 2007-12-04 2022-11-29 Alnylam Pharmaceuticals, Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
CN109912487B (zh) * 2019-03-25 2023-01-10 山东理工大学 一种合成1-对甲苯磺酰基-2-乙烯基-1氢-吡咯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
US4282243A (en) * 1972-04-03 1981-08-04 A. H. Robins Company, Inc. Optical isomers of 4-amino-N-(1-cyclohexyl-3-pyrrolidinyl)-N-methylbenzamide
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
EP0042639B1 (en) * 1980-06-23 1984-08-22 E.R. Squibb & Sons, Inc. Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity
GB8509703D0 (en) * 1985-04-16 1985-05-22 Fujisawa Pharmaceutical Co Pyrrolidine derivatives
US4785119A (en) * 1985-10-11 1988-11-15 Tokyo Kasei Kogyo Co., Ltd. 3-aminopyrrolidine compound and process for preparation thereof
JPH07108898B2 (ja) * 1986-08-20 1995-11-22 大日本製薬株式会社 ３−アミノピロリジン誘導体およびその塩の製造法
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718031B2 (en) 2005-01-05 2010-05-18 Samsung Mobile Display Co., Ltd. Mask frame and method of fixing mask on the mask frame

Also Published As

Publication number Publication date
EP0289911B1 (en) 1993-06-16
EP0289911A2 (en) 1988-11-09
JPS63295553A (ja) 1988-12-01
FI88716B (fi) 1993-03-15
FI882015L (fi) 1988-11-02
NO173330B (no) 1993-08-23
IL86173A (en) 1992-02-16
DE3881755T2 (de) 1993-10-21
KR880013889A (ko) 1988-12-22
AU613360B2 (en) 1991-08-01
IL86173A0 (en) 1988-11-15
US4916152A (en) 1990-04-10
HU208671B (en) 1993-12-28
CA1329391C (en) 1994-05-10
PH24950A (en) 1990-12-26
IE62862B1 (en) 1995-03-08
FI88716C (fi) 1993-06-28
HUT48579A (en) 1989-06-28
AU1534888A (en) 1988-11-03
FI882015A0 (fi) 1988-04-29
ES2054729T3 (es) 1994-08-16
DK233888A (da) 1988-11-02
IE881260L (en) 1988-11-01
PT87359B (pt) 1992-08-31
CN88102511A (zh) 1988-11-23
NO881884L (no) 1988-11-02
AR247879A1 (es) 1995-04-28
CN1020899C (zh) 1993-05-26
NO173330C (no) 1993-12-01
JPH0546335B2 (enExample) 1993-07-13
EP0289911A3 (en) 1989-08-16
DK233888D0 (da) 1988-04-28
PT87359A (pt) 1989-05-31
DE3881755D1 (de) 1993-07-22
NO881884D0 (no) 1988-04-29

Similar Documents

Publication Publication Date Title
US6677333B1 (en) 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient
AU661616B2 (en) Benzo-fused lactams
US6350749B1 (en) Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
KR0183397B1 (ko) 단백질 분해 효소 저해제로서 유용한 사카린 유도체들 및 그의 제조방법
CA2311428A1 (en) Anilide derivative, production and use thereof
EP0514133A1 (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
DE3826371A1 (de) Tetrahydro-1-benz-(c,d)-indolpropionsaeure-sulfonamide
NZ204039A (en) 1-sulpho-2-oxoazetidine derivatives and antimicrobial compositions
IE65374B1 (en) Substituted sulfonamides process of preparation and medicaments containing them
KR970005190B1 (ko) 피롤리딘 유도체
KR19990071666A (ko) 술파미드 유도체
US4388314A (en) Heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid
WO1998015525A1 (en) Hydroxamic acids
EP0649843B1 (en) Thiazoline derivative
AU1434292A (en) Indoles useful as platelet activating factor antagonists
KR19990035780A (ko) Ｐｌａ２ 억제제로서의 에스테르 및 아미드
NO885117L (no) Substituerte hydroksylaminer.
DE68927286T2 (de) Pyrrolidin-Derivate
JP3473956B2 (ja) 抗増殖剤およびｇａｒｆｔ阻害剤として有用な化合物
JPH02209861A (ja) アミノ酸誘導体及び該誘導体を有効成分として含有するエンケファリナーゼ阻害剤
JP3165866B2 (ja) 含硫黄複素環化合物
JPH0881443A (ja) 細胞外マトリックス金属プロテアーゼ阻害剤
RU2095346C1 (ru) Производные пирролидина и их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция
JPH02193965A (ja) 新規な２―ハロゲン置換ｎ―インドリルエチル―スルホンアミド、それらの製造方法、及び薬物におけるそれらの使用
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20000923

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20000923